Concise total synthesis of (+)-Zeylenone with antitumor activity and the structure-activity relationship of its derivatives.


Journal

Bioorganic chemistry
ISSN: 1090-2120
Titre abrégé: Bioorg Chem
Pays: United States
ID NLM: 1303703

Informations de publication

Date de publication:
11 2021
Historique:
received: 08 05 2021
revised: 13 07 2021
accepted: 01 09 2021
pubmed: 20 9 2021
medline: 5 1 2022
entrez: 19 9 2021
Statut: ppublish

Résumé

Natural products--polyoxygenated cyclohexenes exhibited potent anti-tumor activity, such as zeylenone, which is a natural product isolated from Uvaria grandiflora Roxb. This article will attempt to establish a gram-scale synthesis method of (+)-zeylenone and explain the structure-activity relationship of this kind of compound. Total synthesis of (+)-zeylenone was completed in 13 steps with quinic acid as the starting material in 9.8% overall yield. The highlight of the route was the control of the three carbon's chirality by single step dihydroxylation. In addition, different kinds of derivatives were designed and synthesized. Cell Counting Kit-8 (CCK8) assay was used for evaluating antitumor activity against three human cancer cell lines. The structure--activity relationship suggested that compounds with both absolute configurations exhibited tumor-suppressive effects. Moreover, hydroxyls at the C-1/C-2 position were crucial to the activity, and the esterification of large groups at C-1 hydroxyl eliminated the activity. Hydroxyl at the C-3 position was also important as proper ester substituent could increase the potency.

Identifiants

pubmed: 34537516
pii: S0045-2068(21)00710-0
doi: 10.1016/j.bioorg.2021.105333
pii:
doi:

Substances chimiques

Antineoplastic Agents, Phytogenic 0
Cyclohexanes 0
Dioxanes 0
zeylenone 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

105333

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Zhonghao Sun (Z)

Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, PR China; Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, PR China; Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, PR China.

Shuxian Yang (S)

Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, PR China; Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, PR China; Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, PR China.

Chengfang Xu (C)

China Agricultural University, Beijing 100193, PR China.

Fan Yi (F)

Beijing Key Laboratory of Plant Resources Research and Development, Beijing Technology and Business University, Beijing 100048, PR China.

Li Cao (L)

Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, PR China; Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, PR China; Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, PR China.

Yu Tian (Y)

Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, PR China; Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, PR China; Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, PR China.

Jiahao Lin (J)

China Agricultural University, Beijing 100193, PR China.

Xudong Xu (X)

Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, PR China; Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, PR China; Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, PR China. Electronic address: xdxu@implad.ac.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH